Therapeutic effect of berberine against 5-fluorouracil induced ovarian toxicity in rats
Göster/ Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2024Yazar
Demir, SelimTürkmen Alemdar, Nihal
Küçük, Hatice
Ayazoğlu Demir, Elif
Menteşe, Ahmet
Aliyazıcıoğlu, Yüksel
Üst veri
Tüm öğe kaydını gösterKünye
Demir, S., Turkmen Alemdar, N., Kucuk, H., Ayazoglu Demir, E., Menteşe, A., & Aliyazıcıoğlu, Y. (2024). Therapeutic effect of berberine against 5-fluorouracil induced ovarian toxicity in rats. Biotechnic & Histochemistry, 1–7. https://doi.org/10.1080/10520295.2024.2415005Özet
Berberine (BER) is a naturally occurring alkaloid with a multitude of beneficial effects on human health. Although it is one of the most studied phytochemicals, its curative effect against ovarian damage caused by 5-fluorouracil (5-FU) has not been demonstrated to date. The aim of this study was to investigate the possible protective effect of BER against 5-FU-induced ovotoxicity, focusing on its ability to attenuate oxidative stress, inflammation and apoptosis. The 30 female rats were randomly divided into five groups: Control, BER (2 mg/kg), 5-FU (100 mg/kg), 5-FU+BER (1 mg/kg) and 5-FU+BER (2 mg/kg). The levels of malondialdehyde (MDA), total oxidant status (TOS), total antioxidant status (TAS), superoxide dismutase (SOD), catalase (CAT), 8-hydroxy-2’-deoxyguanosine (8-OHdG), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and caspase-3 were determined using spectrophotometric methods. In addition, ovarian samples were evaluated histopathologically using hematoxylin&eosin staining method. The MDA, TOS, 8-OHdG, IL-6, TNF-α and caspase-3 levels significantly increased by 5-FU administration. Also, we found that 5-FU significantly decreased TAS, SOD and CAT levels. Treatments with BER significantly attenuated the 5-FU-induced ovarian damage via increasing the antioxidant capacity and reducing the oxidative stress, inflammation and apoptosis in a dose-dependent manner. Moreover, the ovoprotective effect of BER was also confirmed by histopathological evaluation. BER may be evaluated as a potential candidate molecule to reduce 5-FU-induced ovarian toxicity.